Literature DB >> 17388619

Comparative time-dependent analysis of potential inflammation biomarkers in lymphoma-bearing SJL mice.

Monica H Kristiansson1, Vadiraja B Bhat, I Ramesh Babu, John S Wishnok, Steven R Tannenbaum.   

Abstract

SJL mice colonized with RcsX lymphoma cells undergo a rapid inflammatory response associated with biological and physiological effects including increased nitric oxide production and mutations in spleen DNA. By 2 weeks postcolonization, these changes were accompanied by both up- and down-regulation of a number of plasma proteins. In the experiments reported here, plasma from individual SJL mice was analyzed at several time-points over the 2-week period to determine if there were sets of proteins whose expression varied in concert and thus might serve as early biomarkers for inflammation-related disorders. Samples were collected just prior to injection of the RcsX cells and then after 4, 8, and 12 days. Albumin and immunoglobulins were depleted, and the samples were resolved by 1D gel electrophoresis. The gels were cut into 20 slices, and the proteins were digested in-gel with trypsin. The digests were treated with iTRAQ reagents and then analyzed using LC/MS/MS. The resulting data were processed with two software packages, that is, ProQuant and Spectrum Mill, and then subjected to K-means cluster analysis (K = 4). The four clusters revealed a set of highly up-regulated proteins, a set of progressively up-regulated proteins, a set with no major changes, and a set that declined. The first cluster included haptoglobin and serum amyloid A; the second included groups with several functions including protease inhibition, cell motility, and transport. The iTRAQ results for a selection of the up-regulated proteins, including haptoglobin, hemopexin, serum amyloid P component, and ceruloplasmin, were confirmed with Western blots. Prominent down-regulated proteins included esterase-1, paraoxonase, and alpha-2-macroglobulin. Approximately 50% of the up-regulated proteins are canonical acute phase proteins, while the remainder are regulated by the Nrf2 transcription factor.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17388619      PMCID: PMC2532589          DOI: 10.1021/pr060497x

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  47 in total

Review 1.  Acute-phase reactants in infections and inflammatory diseases.

Authors:  J L Ebersole; D Cappelli
Journal:  Periodontol 2000       Date:  2000-06       Impact factor: 7.589

Review 2.  The human plasma proteome: history, character, and diagnostic prospects.

Authors:  N Leigh Anderson; Norman G Anderson
Journal:  Mol Cell Proteomics       Date:  2002-11       Impact factor: 5.911

3.  The human plasma proteome: a nonredundant list developed by combination of four separate sources.

Authors:  N Leigh Anderson; Malu Polanski; Rembert Pieper; Tina Gatlin; Radhakrishna S Tirumalai; Thomas P Conrads; Timothy D Veenstra; Joshua N Adkins; Joel G Pounds; Richard Fagan; Anna Lobley
Journal:  Mol Cell Proteomics       Date:  2004-01-12       Impact factor: 5.911

Review 4.  A physiological function of serum proteoglycan bikunin: the chondroitin sulfate moiety plays a central role.

Authors:  Lisheng Zhuo; Antonietta Salustri; Koji Kimata
Journal:  Glycoconj J       Date:  2002 May-Jun       Impact factor: 2.916

5.  Comparative proteomic analysis of intra- and interindividual variation in human cerebrospinal fluid.

Authors:  Yan Hu; James P Malone; Anne M Fagan; R Reid Townsend; David M Holtzman
Journal:  Mol Cell Proteomics       Date:  2005-09-30       Impact factor: 5.911

6.  Up-regulation of MHC class I expression accompanies but is not required for spontaneous myopathy in dysferlin-deficient SJL/J mice.

Authors:  Christine A Kostek; Janice A Dominov; Jeffrey Boone Miller
Journal:  Am J Pathol       Date:  2002-03       Impact factor: 4.307

Review 7.  Different faces of the heme-heme oxygenase system in inflammation.

Authors:  Frank A D T G Wagener; Hans-Dieter Volk; Dean Willis; Nader G Abraham; Miguel P Soares; Gosse J Adema; Carl G Figdor
Journal:  Pharmacol Rev       Date:  2003-07-17       Impact factor: 25.468

8.  Analysis of nitrated proteins by nitrotyrosine-specific affinity probes and mass spectrometry.

Authors:  George Nikov; Vadiraja Bhat; John S Wishnok; Steven R Tannenbaum
Journal:  Anal Biochem       Date:  2003-09-15       Impact factor: 3.365

9.  Modulation of gene expression by cancer chemopreventive dithiolethiones through the Keap1-Nrf2 pathway. Identification of novel gene clusters for cell survival.

Authors:  Mi-Kyoung Kwak; Nobunao Wakabayashi; Ken Itoh; Hozumi Motohashi; Masayuki Yamamoto; Thomas W Kensler
Journal:  J Biol Chem       Date:  2002-12-27       Impact factor: 5.157

Review 10.  Reactive nitrogen species in the chemical biology of inflammation.

Authors:  Peter C Dedon; Steven R Tannenbaum
Journal:  Arch Biochem Biophys       Date:  2004-03-01       Impact factor: 4.013

View more
  7 in total

1.  Simultaneous analysis of relative protein expression levels across multiple samples using iTRAQ isobaric tags with 2D nano LC-MS/MS.

Authors:  Richard D Unwin; John R Griffiths; Anthony D Whetton
Journal:  Nat Protoc       Date:  2010-08-26       Impact factor: 13.491

2.  Nrf2 to pre-condition the brain against injury caused by products of hemolysis after ICH.

Authors:  Xiurong Zhao; Jaroslaw Aronowski
Journal:  Transl Stroke Res       Date:  2013-02       Impact factor: 6.829

Review 3.  Secondary Brain Injury by Oxidative Stress After Cerebral Hemorrhage: Recent Advances.

Authors:  Linqian Shao; Sichao Chen; Li Ma
Journal:  Front Cell Neurosci       Date:  2022-06-23       Impact factor: 6.147

Review 4.  Serum amyloid A: an acute-phase protein involved in tumour pathogenesis.

Authors:  E Malle; S Sodin-Semrl; A Kovacevic
Journal:  Cell Mol Life Sci       Date:  2009-01       Impact factor: 9.261

5.  Metabolites of purine nucleoside phosphorylase (NP) in serum have the potential to delineate pancreatic adenocarcinoma.

Authors:  Shaiju K Vareed; Vadiraja B Bhat; Christopher Thompson; Vihas T Vasu; Damian Fermin; Hyungwon Choi; Chad J Creighton; Sitaram Gayatri; Ling Lan; Nagireddy Putluri; Gagan Singh Thangjam; Punit Kaur; Mohsen Shabahang; Judith G Giri; Alexey I Nesvizhskii; Alexander A A Asea; Anil G Cashikar; Arundhati Rao; James McLoughlin; Arun Sreekumar
Journal:  PLoS One       Date:  2011-03-23       Impact factor: 3.240

6.  Trm9-Catalyzed tRNA Modifications Regulate Global Protein Expression by Codon-Biased Translation.

Authors:  Wenjun Deng; I Ramesh Babu; Dan Su; Shanye Yin; Thomas J Begley; Peter C Dedon
Journal:  PLoS Genet       Date:  2015-12-15       Impact factor: 5.917

7.  Integrated glycoproteomics demonstrates fucosylated serum paraoxonase 1 alterations in small cell lung cancer.

Authors:  Jung-Mo Ahn; Hye-Jin Sung; Yeon-Hee Yoon; Byung-Gyu Kim; Won Suk Yang; Cheolju Lee; Hae-Min Park; Bum-Jin Kim; Byung-Gee Kim; Soo-Youn Lee; Hyun-Joo An; Je-Yoel Cho
Journal:  Mol Cell Proteomics       Date:  2013-10-01       Impact factor: 5.911

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.